Approach to New Therapeutics: Investigation by the Use of MDS-derived Cell Lines

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|22|3204-3214

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.22, 2012-07, pp. : 3204-3214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Cell Lines in the Investigation of Pharmacogenetic Loci

By  

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3782-3795

Bentham Science Publishers

Access to resources Recommend Favorite

The use of human tumour cell lines in the discovery of new cancer chemotherapeutic drugs

By Baguley Bruce C   Marshall Elaine S  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 2, 2008-02 ,pp. : 153-161

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay

By Schott Sarah  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1750-1755

Springer Publishing Company

Access to resources Recommend Favorite

Investigation of cancer cell lines for peptide receptor-targeted drug development

By Sun Lichun   Luo Jing   Mackey L. Vienna   Morris Lynsie M.   Franko-Tobin Laura G.   LePage Keith T.   Coy David H.  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 719-730

Informa Healthcare

Access to resources Recommend Favorite

Current Status of Allogeneic Hematopoietic Cell Transplantation for MDS

By  

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3215-3221

Bentham Science Publishers

Access to resources Recommend Favorite